Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Sensex rises 291 points, Nifty tops 24,100 on cooling crude and FII support
Domestic equities advanced on Monday as cooling oil prices and fresh FII inflows fuelled risk appetite. Buying in heavyweight Reliance Industries and healthcare counters propelled the Nifty past the 24,100 level. The gains were partly offset by weakness in consumer durables and FMCG stocks.
Sensex rises 291 points, Nifty tops 24,100: 5 key drivers behind the market rally
Sensex rose 291 to 77094, Nifty gained 90 to 24102, led by HDFC Bank, ICICI Bank, Reliance Industries, Infosys, with IT and pharma stocks like Cipla outperforming
NHB probing Aavas Financiers over loan classification lapses
The sector regulator has recalled refinancing support worth nearly Rs 500 crore —a punitive action that has set off a sweeping leadership overhaul at the company. ET was the first to report on April 13 that managing director and CEO Sachinder Bhinder was being asked to step down, with Manu Singh — former home loans head at Kotak Mahindra Bank — set to take over. A week later, on April 20, the company confirmed Bhinder's resignation and Singh's appointment as the new CEO.
NHB probing Aavas Financiers over loan classification lapses
The sector regulator has recalled refinancing support worth nearly Rs 500 crore —a punitive action that has set off a sweeping leadership overhaul at the company. ET was the first to report on April 13 that managing director and CEO Sachinder Bhinder was being asked to step down, with Manu Singh — former home loans head at Kotak Mahindra Bank — set to take over. A week later, on April 20, the company confirmed Bhinder's resignation and Singh's appointment as the new CEO.
Stocks in news: IFCI, Tata Motors, General Insurance Corp, Corona Remedies, HFCL
Markets extended their winning streak for the fourth consecutive session, driven by favorable global cues and sustained sector-wide buying. The Nifty reclaimed the 24,000 mark, approaching the 100-day EMA near 24,150. Stocks like IFCI, Tata Motors, and HFCL are in focus due to significant news developments, including IPO filings, turnaround projections, and major order wins.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
KIMS launches ₹1,500 crore QIP to repay debt and fund subsidiaries
KIMS has launched a ₹1,500 crore qualified institutions placement (QIP) through a 100% primary share issuance, with the indicative price set at ₹755 per share at up to a 3% discount to the last closing price. The hospital chain plans to use the proceeds to repay debt and fund investments in its subsidiaries, with the issue expected to be priced later this week and listed on the NSE and BSE thereafter.
Ambani-backed robot startup seeks $100 million to take on China
Reliance-backed robotics startup Addverb Technologies is looking to raise over $100 million to fund expansion into humanoid robots, AI and advanced automation. The company, which generates half its revenue overseas, targets a spot among the world's top 10 robotics firms within five years.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.
Sebi may widen 50% overlap rule to thematic passive mutual fund schemes
Curb on number of smart-beta schemes also likely; move aimed at curbing proliferation in segment
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.